Location: Home
  • search
  • go
  • Relate News
  • 4/18/2018China Publishes First Health Management Bluebook
  • 4/18/2018Takeda Launches Multiple Myeloma Drug Ninlaro in China
  • 4/18/2018CNDA Outlines Five Focal Areas of Its Work in 2018
  • 4/18/2018Morphotek Licenses Its Eribulin-Linker Payload To Bliss Bio
  • 4/18/2018China Announces New Initiatives to Level the Playing Field for Innovat...
  • 4/17/2018BeiGene Presents Clinical Data on Pamiparib in Chinese Patients
  • 4/17/2018U.S. Businesses Worried over Chinese Policy Initiative
  • 4/17/2018China Will Always Be Bad at Bioethics
  • 4/17/2018Why Immuno-Therapy Is Leaving Markets Abuzz Across the World
  • 4/17/2018Goldman Sachs: China Is Beating the U.S. in the Gene Editing Arms Race
  • 4/17/2018Alliance Pharma Sells Chinese JV and Rights of Pregnancy Supplement fo...
  • 4/17/2018China Performance of Korean Pharma Cos Mixed in 2017 with Hanmi and Il...
  • 4/17/2018GlobalData: Chinese Pharma Regulatory Reforms to Help Attract Foreign ...
  • 4/17/2018China to Cut Review Time for Clinical Trial Applications with Plan to ...
  • 4/17/2018JHL Files Clinical Trial Application for Avastin (Bevacizumab) Biosimi...
  • 4/16/2018China to Roll Out New Measures to Boost Internet + Healthcare
  • 4/16/2018China to Set Up Hainan Free Trade Zone, Further Benefiting Medical Tou...
  • 4/16/2018Opdivo (Nivolumab) Improves Survival in Pretreated Chinese NSCLC Patie...
  • 4/13/2018State Council Removes Import Duties on Anticancers as It Proposes New ...
  • 4/13/2018Top A Share-listed Chinese Pharma Companies by R&D Investment 2017
  • 4/13/2018CNDA Issues New Announcement (2018#2) for Clinical Data Self-Inspectio...
  • 4/13/2018CNDA Publishes 2017 Annual Report for Adverse Drug Reaction Monitoring
  • 4/13/2018State Council Lays Out Tasks in Healthcare and Pharmaceutical System R...
  • 4/13/2018CANbridge Receives IND Approval to Commence CAN008 Phase II/III Trial ...
  • 4/12/2018Nicholas Hall Projects Chinese OTC Drug Market to Grow 6% CAGR in the ...
  • 4/12/2018Nicholas Hall's Review of China's OTC Drug Market Performance 2017
  • 4/12/2018China's Relatively Small Central Government Healthcare Budget Surge 55...
  • 4/12/2018Bloomburg: China Is Nationalizing Its Tech Sector
  • 4/12/2018Chinese Investor Group Snaps Up Majority of Nature's Care for $620M
  • 4/12/2018Klockner Pentaplast Expands Pharma Capacity in China
  • Page:360/807 Total number of articles:24202: [First][<<] [358] [359] [360] [361] [362] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group